Histamine-1 Receptor Antagonist class drugs

10 results
  • azelastine hydrochloride

    (Azelastine)
    AvKARE
    Azelastine hydrochloride nasal spray, 0.1%, is indicated for treating symptoms of seasonal allergic rhinitis in individuals 5 years and older, and for vasomotor rhinitis in those 12 years and older.
  • carbinoxamine maleate

    (CARBINOXAMINE MALEATE)
    BluCrest Pharmaceuticals, LLC
    Carbinoxamine maleate is indicated for the symptomatic treatment of seasonal and perennial allergic rhinitis, vasomotor rhinitis, allergic conjunctivitis, mild allergic skin manifestations, dermatographism, and as an adjunctive therapy for anaphylactic reactions and allergic reactions to blood or plasma.
  • carbinoxamine maleate

    (Carbinoxamine Maleate)
    Biocomp Pharma, Inc.
    Carbinoxamine maleate is indicated for the symptomatic treatment of seasonal and perennial allergic rhinitis, vasomotor rhinitis, allergic conjunctivitis, mild allergic skin conditions, dermatographism, as adjunct therapy for anaphylactic reactions, and to reduce the severity of allergic reactions to blood or plasma.
  • cetirizine hydrochloride

    (CETIRIZINE HYDROCHLORIDE)
    Rising Pharma Holdings, Inc.
    Cetirizine hydrochloride oral solution is indicated for treating uncomplicated skin manifestations of chronic idiopathic urticaria in adults and children aged 6 months to 5 years, significantly reducing the occurrence, severity, and duration of hives and alleviating itching.
  • cetirizine hydrochloride oral solution

    (Cetirizine Hydrochloride Oral Solution)
    APOZEAL PHARMACEUTICALS INC
    Cetirizine Hydrochloride Oral Solution is indicated for relieving symptoms of perennial allergic rhinitis in children 6 to 23 months and treating chronic idiopathic urticaria in children 6 months to 5 years, effectively reducing sneezing, nasal and ocular symptoms, and hive-related discomfort.
  • desloratadine

    (DESLORATADINE)
    Lupin Pharmaceuticals, Inc.
    Desloratadine tablets are indicated for relieving nasal and non-nasal symptoms of seasonal and perennial allergic rhinitis in patients aged 12 and older.
  • dymista

    (Azelastine Hydrochloride and Fluticasone Propionate)
    Meda Pharmaceuticals Inc.
    DYMISTA is indicated for the relief of symptoms of seasonal allergic rhinitis in adults and children aged 6 years and older.
  • levocetirizine dihydrochloride

    (levocetirizine dihydrochloride)
    Glenmark Pharmaceuticals Inc., USA
    Levocetirizine dihydrochloride is indicated for relieving symptoms of perennial allergic rhinitis in children aged 6 months to 2 years and for treating uncomplicated skin manifestations of chronic idiopathic urticaria in adults and children 6 months and older.
  • levocetirizine dihydrochloride

    (Levocetirizine dihydrochloride)
    Padagis Israel Pharmaceuticals Ltd
    Levocetirizine dihydrochloride is indicated for relieving symptoms of perennial allergic rhinitis in children aged 6 months to 2 years and for treating uncomplicated skin manifestations of chronic idiopathic urticaria in adults and children aged 6 months and older.